Edward White
Stock Analyst at HC Wainwright & Co.
(1.87)
# 3,237
Out of 5,124 analysts
362
Total ratings
31.4%
Success rate
-8.1%
Average return
Main Sectors:
Stocks Rated by Edward White
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CGEM Cullinan Therapeutics | Reiterates: Buy | $33 | $10.35 | +218.84% | 24 | Apr 16, 2025 | |
| VALN Valneva SE | Reiterates: Buy | $17 | $8.86 | +91.87% | 41 | Apr 15, 2025 | |
| NYXH Nyxoah | Reiterates: Buy | $15 | $4.60 | +226.09% | 15 | Apr 8, 2025 | |
| SABS SAB Biotherapeutics | Reiterates: Buy | $6 | $3.74 | +60.43% | 15 | Apr 1, 2025 | |
| CRIS Curis | Maintains: Buy | $20 → $16 | $0.99 | +1,520.91% | 18 | Mar 31, 2025 | |
| IKT Inhibikase Therapeutics | Reiterates: Neutral | n/a | $2.05 | - | 11 | Mar 28, 2025 | |
| SNSE Sensei Biotherapeutics | Reiterates: Buy | $80 | $10.67 | +649.77% | 6 | Mar 28, 2025 | |
| SXTP 60 Degrees Pharmaceuticals | Reiterates: Neutral | n/a | $0.51 | - | 11 | Mar 28, 2025 | |
| ARTV Artiva Biotherapeutics | Reiterates: Buy | $20 | $4.29 | +366.20% | 2 | Mar 26, 2025 | |
| BOLT Bolt Biotherapeutics | Reiterates: Neutral | n/a | $5.47 | - | 12 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $16 | $3.81 | +319.95% | 7 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $5.45 | +358.72% | 6 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.01 | +692.08% | 25 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $18.16 | - | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $8.42 | - | 23 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $29.81 | +84.50% | 31 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $51 | $21.01 | +142.74% | 29 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $5.95 | +17.65% | 20 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $56 | $7.36 | +660.87% | 28 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $31 | $15.38 | +101.56% | 21 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $101 → $52 | $10.21 | +409.30% | 4 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $0.72 | - | 1 | Nov 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $700 | $28.93 | +2,319.63% | 3 | Aug 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $30 | $34.57 | -13.22% | 5 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 | $0.98 | +1,121.25% | 2 | Mar 6, 2018 |
Cullinan Therapeutics
Apr 16, 2025
Reiterates: Buy
Price Target: $33
Current: $10.35
Upside: +218.84%
Valneva SE
Apr 15, 2025
Reiterates: Buy
Price Target: $17
Current: $8.86
Upside: +91.87%
Nyxoah
Apr 8, 2025
Reiterates: Buy
Price Target: $15
Current: $4.60
Upside: +226.09%
SAB Biotherapeutics
Apr 1, 2025
Reiterates: Buy
Price Target: $6
Current: $3.74
Upside: +60.43%
Curis
Mar 31, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $0.99
Upside: +1,520.91%
Inhibikase Therapeutics
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.05
Upside: -
Sensei Biotherapeutics
Mar 28, 2025
Reiterates: Buy
Price Target: $80
Current: $10.67
Upside: +649.77%
60 Degrees Pharmaceuticals
Mar 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.51
Upside: -
Artiva Biotherapeutics
Mar 26, 2025
Reiterates: Buy
Price Target: $20
Current: $4.29
Upside: +366.20%
Bolt Biotherapeutics
Mar 25, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.47
Upside: -
Mar 25, 2025
Maintains: Buy
Price Target: $15 → $16
Current: $3.81
Upside: +319.95%
Mar 25, 2025
Maintains: Buy
Price Target: $22 → $25
Current: $5.45
Upside: +358.72%
Mar 21, 2025
Reiterates: Buy
Price Target: $8
Current: $1.01
Upside: +692.08%
Mar 20, 2025
Reiterates: Neutral
Price Target: n/a
Current: $18.16
Upside: -
Mar 7, 2025
Reiterates: Neutral
Price Target: n/a
Current: $8.42
Upside: -
Mar 4, 2025
Reiterates: Buy
Price Target: $55
Current: $29.81
Upside: +84.50%
Mar 4, 2025
Reiterates: Buy
Price Target: $51
Current: $21.01
Upside: +142.74%
Feb 28, 2025
Reiterates: Buy
Price Target: $7
Current: $5.95
Upside: +17.65%
Feb 26, 2025
Maintains: Buy
Price Target: $7 → $56
Current: $7.36
Upside: +660.87%
Feb 21, 2025
Reiterates: Buy
Price Target: $31
Current: $15.38
Upside: +101.56%
Aug 5, 2022
Downgrades: Neutral
Price Target: $101 → $52
Current: $10.21
Upside: +409.30%
Nov 8, 2021
Initiates: Neutral
Price Target: n/a
Current: $0.72
Upside: -
Aug 30, 2021
Initiates: Buy
Price Target: $700
Current: $28.93
Upside: +2,319.63%
Aug 11, 2021
Maintains: Buy
Price Target: $34 → $30
Current: $34.57
Upside: -13.22%
Mar 6, 2018
Downgrades: Neutral
Price Target: $12
Current: $0.98
Upside: +1,121.25%